ledercort "rx" 50 mikrogram/dosis næsespray, suspension
dymalife pharmaceutical srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
xifaxan 550 mg filmovertrukne tabletter
norgine b.v. - rifaximin - filmovertrukne tabletter - 550 mg
xifaxan 550 mg filmovertrukne tabletter
orifarm a/s - rifaximin - filmovertrukne tabletter - 550 mg
tixteller 550 mg filmovertrukne tabletter
orifarm a/s - rifaximin - filmovertrukne tabletter - 550 mg
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotiske midler - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
varuby
tesaro bio netherlands b.v. - rolapitant - vomiting; nausea; cancer - antiemetika og antinauseants, - forebyggelse af forsinket kvalme og opkastning i forbindelse med høj og moderat emetogen kræftkemoterapi hos voksne. varuby er givet som en del af kombinationsbehandling.
clozapine "actavis" 25 mg tabletter
actavis group ptc ehf. - clozapin - tabletter - 25 mg
otrason 50 mikrogram/dosis næsespray, suspension
haleon denmark aps - fluticasonpropionat - næsespray, suspension - 50 mikrogram/dosis
panodil 500 mg filmovertrukne tabletter
haleon denmark aps - paracetamol - filmovertrukne tabletter - 500 mg
panodil zapp 500 mg filmovertrukne tabletter
haleon denmark aps - paracetamol - filmovertrukne tabletter - 500 mg